Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-04-15

FDA Approved: PANTOPRAZOLE SODIUM I.V. — Supplemental Application (Piramal Critical Care)

View source ↗

Summary

The FDA approved a supplemental application for Pantoprazole Sodium for Injection (IV), submitted by Piramal Critical Care, enabling its continued/expanded intr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pantoprazole sodium IV (pantoprazole sodium)

Snippet

SUPPL AP for PANTOPRAZOLE SODIUM I.V. (PANTOPRAZOLE SODIUM)